Izenwasser S, Newman A H, Cox B M, Katz J L
Division of Intramural Research, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224, USA.
Eur J Pharmacol. 1996 Feb 15;297(1-2):9-17. doi: 10.1016/0014-2999(95)00696-6.
Meperidine has atypical opioid receptor agonist effects and shares some structural features with the phenyltropane (WIN) analogs of cocaine. In combination with 0.1 mg/kg naltrexone, meperidine produced cocaine-like discriminative stimulus effects in monkeys, whereas morphine was inactive. Both cocaine and meperidine inhibited [3H]dopamine uptake in chopped rat caudate putamen with comparable potencies; meperidine differed from cocaine in that its effects could be characterized as having predominantly a single high-affinity component. Morphine was not active in inhibiting [3H]dopamine uptake, indicating that the effect of meperidine was not via a classic mu-opioid receptor agonist action. Further, meperidine but not morphine displaced [3H]WIN 35,428 (2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane) binding. These data suggest that the actions of meperidine that are atypical of opioids are due to activity at the dopamine transporter. In addition, meperidine appears to interact predominantly with the high-affinity component of the dopamine transporter, and this high-affinity component may be the site of importance for the production of cocaine's behavioral effects.
哌替啶具有非典型的阿片受体激动剂作用,并且与可卡因的苯基托烷(WIN)类似物具有一些结构特征。与0.1mg/kg的纳曲酮联合使用时,哌替啶在猴子身上产生了类似可卡因的辨别刺激效应,而吗啡则无活性。可卡因和哌替啶对大鼠尾状核壳核切片中[3H]多巴胺摄取的抑制作用具有相当的效力;哌替啶与可卡因的不同之处在于,其作用主要表现为单一的高亲和力成分。吗啡对[3H]多巴胺摄取无抑制作用,表明哌替啶的作用并非通过经典的μ-阿片受体激动剂作用。此外,哌替啶而非吗啡能取代[3H]WIN 35,428(2β-甲氧羰基-3β-(4-氟苯基)托烷)的结合。这些数据表明,哌替啶非典型的阿片类作用是由于其对多巴胺转运体的活性。此外,哌替啶似乎主要与多巴胺转运体的高亲和力成分相互作用,而这种高亲和力成分可能是产生可卡因行为效应的重要位点。